ICONEUS is a French startup founded in 2016, specializing in delivering functional ultrasound (fUS) imaging solutions aimed at helping scientists comprehend brain function. The company's slogan, "Delivering functional ultrasound (fUS) imaging solutions to help scientists understand the Brain function," underscores its focus on advancing neuro-imaging technology.
ICONEUS's flagship offering is real-time portable functional ultrasound neuro-imaging. This breakthrough imaging modality monitors brain activity by imaging blood flow with ultra-high sensitivity. The portability and high versatility of the technology enable studying brain activity at unprecedented scales and in various subject states, such as awake, behaving, freely-moving, resting-state, and asleep conditions.
Moreover, ICONEUS's technology can be seamlessly integrated with other modalities like eeg headstage or optogenetics, which are inherently challenging to combine with fmri. The company also provides essential applications such as functional connectivity assessment between brain structures and stroke 4D monitoring.
Having leveraged years of preclinical expertise and research, ICONEUS is now increasing its investment in pioneering new clinical applications. This initiative involves utilizing the Iconeus One CR functional ultrasound system dedicated to clinical research.
Specializing in Biotechnology, Health Care, and Medical Devices, ICONEUS is poised to make significant strides in the neuro-imaging space, positioning itself as a promising investment opportunity for venture capitalists seeking to tap into the burgeoning field of brain research and medical imaging technologies.
There is no investment information
No recent news or press coverage available for ICONEUS.